← Back to Search

best side reduction for Parkinson's Disease

N/A
Waitlist Available
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Idiopathic Parkinson's disease
Hoehn & Yahr Stage 1-3
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within intervention (2mins for each situation)
Awards & highlights

Study Summary

This study is evaluating whether a surgery which reduces blood flow in a stomach artery leads to significant weightloss.

Eligible Conditions
  • Parkinson's Disease
  • Freezing of Gait

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within intervention (2mins for each situation)
This trial's timeline: 3 weeks for screening, Varies for treatment, and within intervention (2mins for each situation) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
number of freezing of gait
Secondary outcome measures
Comparison of number/duration of provoked freezing of gait among the situations between Parkinson's disease patients with and without freezing of gait
Correlation with Montreal cognitive assessment, Movement Disorders Society-unified Parkinson's disease rating scale part 2 and 3, Activities-Specific Balance Confidence Scale, Parkinson's disease questionnaire-39, and New freezing of gait questionnaire

Trial Design

16Treatment groups
Experimental Treatment
Active Control
Group I: normal walking passing through narrow pathwayExperimental Treatment1 Intervention
Group II: fast walking with dual taskExperimental Treatment2 Interventions
Group III: fast walking reducing the best side with cognitive dual taskExperimental Treatment3 Interventions
Group IV: fast walking reducing the best side passing through narrow pathway and during cognitive dual taskExperimental Treatment4 Interventions
Group V: fast walking reducing the best side passing through narrow pathwayExperimental Treatment3 Interventions
Group VI: fast walking reducing the best sideExperimental Treatment2 Interventions
Group VII: fast walking passing through narrow pathway and during cognitive dual taskExperimental Treatment3 Interventions
Group VIII: fast walking passing through narrow pathwayExperimental Treatment2 Interventions
Group IX: fast walkingExperimental Treatment1 Intervention
Group X: Natural walking with dual taskExperimental Treatment1 Intervention
Group XI: Natural walking reducing the best side with cognitive dual taskExperimental Treatment2 Interventions
Group XII: Natural walking reducing the best side passing through narrow pathway and during cognitive dual taskExperimental Treatment3 Interventions
Group XIII: Natural walking reducing the best side passing through narrow pathwayExperimental Treatment2 Interventions
Group XIV: Natural walking reducing the best sideExperimental Treatment1 Intervention
Group XV: Natural walking passing through narrow pathway and during cognitive dual taskExperimental Treatment2 Interventions
Group XVI: Natural walkingActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
689 Previous Clinical Trials
1,018,623 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Quality of Life ResearchJournal
The Development and Validation of a Short Measure of Functioning and Well Being for Individuals with Parkinson's Disease
Peto, V., C. Jenkinson, R. Fitzpatrick, and R. Greenhall. 1995. “The Development and Validation of a Short Measure of Functioning and Well Being for Individuals with Parkinson's Disease”. Quality of Life Research. Springer Science and Business Media LLC. doi:10.1007/bf02260863.
Gait & PostureJournal
Reliability of the New Freezing of Gait Questionnaire: Agreement Between Patients with Parkinson's Disease and Their Carers
Nieuwboer, Alice, Lynn Rochester, Talia Herman, Wim Vandenberghe, George Ehab Emil, Tom Thomaes, and Nir Giladi. 2009. “Reliability of the New Freezing of Gait Questionnaire: Agreement Between Patients with Parkinson's Disease and Their Carers”. Gait & Posture. Elsevier BV. doi:10.1016/j.gaitpost.2009.07.108.
Movement DisordersJournal
Freezing Phenomenon in Patients with Parkinsonian Syndromes
Giladi, Nir, Richard Kao, and Stanley Fahn. 1997. “Freezing Phenomenon in Patients with Parkinsonian Syndromes”. Movement Disorders. Wiley. doi:10.1002/mds.870120307.
Movement DisordersJournal
Movement Disorder Society-sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results
Goetz, Christopher G., Barbara C. Tilley, Stephanie R. Shaftman, Glenn T. Stebbins, Stanley Fahn, Pablo Martinez-Martin, Werner Poewe, et al.. 2008. “Movement Disorder Society-sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results”. Movement Disorders. Wiley. doi:10.1002/mds.22340.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top